• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

粪便钙卫蛋白的个体内变异性:活动性溃疡性结肠炎患者的前瞻性研究。

The intra-individual variability of faecal calprotectin: a prospective study in patients with active ulcerative colitis.

机构信息

Department of Internal Medicine, Södra Älvsborgs Hospital, Borås, Sweden

Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.

出版信息

J Crohns Colitis. 2015 Jan;9(1):26-32. doi: 10.1016/j.crohns.2014.06.002.

DOI:10.1016/j.crohns.2014.06.002
PMID:25008478
Abstract

BACKGROUND AND AIMS

Leukocyte-derived proteins in faeces, especially calprotectin, are increasingly used to assess disease activity in ulcerative colitis. The objectives of the present study were to assess the importance of factors related to the stool sampling procedure.

METHODS

For 2 days, patients with active ulcerative colitis collected two stool samples at each bowel movement. The time of defecation, consistency and presence of blood were self-recorded in a diary. The variability in the concentrations of calprotectin during the day and between two consecutive days was assessed, as was the stability of calprotectin concentrations in samples stored at room temperature.

RESULTS

Altogether, 18 patients collected 287 stool samples. The intraclass correlation coefficient in pairs of samples from 132 bowel movements was 0.79 (95% CI 0.48-0.90). The median individual coefficient of variation in samples collected during the same day was 52% (4-178). There was a correlation between the level of calprotectin and the time between bowel movements (r = 0.5; p = 0.013). After 3 days at room temperature the calprotectin concentrations in stool samples were unchanged, but after 7 days a significant (p < 0.01) decrease was found (mean 28%; 95% CI 0.10-0.47).

CONCLUSION

The present data reveal a great variability in the concentrations of calprotectin in stool samples collected during a single day. Since the levels of calprotectin increased with longer time between the bowel movements, it seems most appropriate to analyse stool from the first bowel movement in the morning. Moreover, storage of stool samples at room temperature for more than 3 days is not advisable.

摘要

背景与目的

粪便中白细胞衍生蛋白,尤其是钙卫蛋白,越来越多地用于评估溃疡性结肠炎的疾病活动度。本研究的目的是评估与粪便采样过程相关因素的重要性。

方法

在 2 天内,活动期溃疡性结肠炎患者每次排便时收集 2 份粪便样本。排便时间、粪便稠度和是否带血均记录在日记中。评估日间和连续 2 天钙卫蛋白浓度的变异性,以及室温下储存的粪便样本中钙卫蛋白浓度的稳定性。

结果

共 18 例患者收集了 287 份粪便样本。132 次排便中配对样本的组内相关系数为 0.79(95%CI 0.48-0.90)。同一天采集的样本中个体变异系数中位数为 52%(4-178)。钙卫蛋白水平与排便时间之间存在相关性(r = 0.5;p = 0.013)。室温下储存 3 天后,粪便样本中的钙卫蛋白浓度没有变化,但 7 天后发现明显下降(平均 28%;95%CI 0.10-0.47)。

结论

本研究数据显示,在一天内采集的粪便样本中,钙卫蛋白浓度存在很大的变异性。由于钙卫蛋白水平随排便时间的延长而增加,因此似乎最适合分析早晨首次排便的粪便。此外,不建议将粪便样本储存在室温下超过 3 天。

相似文献

1
The intra-individual variability of faecal calprotectin: a prospective study in patients with active ulcerative colitis.粪便钙卫蛋白的个体内变异性:活动性溃疡性结肠炎患者的前瞻性研究。
J Crohns Colitis. 2015 Jan;9(1):26-32. doi: 10.1016/j.crohns.2014.06.002.
2
Clinical importance of faecal calprotectin variability in inflammatory bowel disease: intra-individual variability and standardisation of sampling procedure.粪便钙卫蛋白变异性在炎症性肠病中的临床重要性:个体内变异性及采样程序的标准化
Scand J Gastroenterol. 2016;51(5):548-55. doi: 10.3109/00365521.2015.1117650. Epub 2015 Dec 4.
3
High within-day variability of fecal calprotectin levels in patients with active ulcerative colitis: what is the best timing for stool sampling?活动期溃疡性结肠炎患者粪便钙卫蛋白水平日内变异性高:粪便采样的最佳时间是什么?
Inflamm Bowel Dis. 2015 May;21(5):1072-6. doi: 10.1097/MIB.0000000000000349.
4
Prediction of endoscopic disease activity in ulcerative colitis by two different assays for fecal calprotectin.两种不同粪便钙卫蛋白检测方法预测溃疡性结肠炎内镜下疾病活动度
J Crohns Colitis. 2015 Feb;9(2):164-9. doi: 10.1093/ecco-jcc/jju015.
5
The value of fecal calprotectin as a marker of intestinal inflammation in patients with ulcerative colitis.粪便钙卫蛋白作为溃疡性结肠炎患者肠道炎症标志物的价值。
Turk J Gastroenterol. 2012;23(5):509-14. doi: 10.4318/tjg.2012.0421.
6
Accuracy of fecal calprotectin for the prediction of endoscopic activity in patients with inflammatory bowel disease.粪便钙卫蛋白对于预测炎症性肠病患者内镜下活动度的准确性。
Dig Liver Dis. 2018 Apr;50(4):353-359. doi: 10.1016/j.dld.2017.12.022. Epub 2017 Dec 30.
7
Rapid Fecal Calprotectin Test and Symptom Index in Monitoring the Disease Activity in Colonic Inflammatory Bowel Disease.快速粪便钙卫蛋白检测与症状指数在监测结肠炎性肠病疾病活动度中的应用
Dig Dis Sci. 2017 Nov;62(11):3123-3130. doi: 10.1007/s10620-017-4770-0. Epub 2017 Sep 25.
8
Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year.抗肿瘤坏死因子α制剂诱导治疗炎症性肠病后粪便钙卫蛋白检测:一年时临床反应和黏膜愈合的预测
Dig Liver Dis. 2014 Nov;46(11):974-9. doi: 10.1016/j.dld.2014.07.013. Epub 2014 Aug 2.
9
Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome.验证一种即时检测台式设备定量检测粪便钙卫蛋白,以区分炎症性肠病和肠易激综合征。
J Crohns Colitis. 2012 Mar;6(2):207-14. doi: 10.1016/j.crohns.2011.08.008. Epub 2011 Sep 7.
10
Comparison of three commercial fecal calprotectin ELISA test kits used in patients with Inflammatory Bowel Disease.三种用于炎症性肠病患者的商用粪便钙卫蛋白酶联免疫吸附测定试剂盒的比较
Scand J Gastroenterol. 2016;51(2):211-7. doi: 10.3109/00365521.2015.1081399. Epub 2015 Sep 11.

引用本文的文献

1
The value of fecal calprotectin measured by fluorescent immunochromatography assay in evaluating clinical and endoscopic activity in ulcerative colitis.荧光免疫层析法检测粪便钙卫蛋白在评估溃疡性结肠炎临床及内镜活动度中的价值。
BMC Gastroenterol. 2025 Aug 7;25(1):566. doi: 10.1186/s12876-025-04200-7.
2
Applying Biomarkers in Treat-to-target Approach for IBD.生物标志物在炎症性肠病达标治疗中的应用
Curr Gastroenterol Rep. 2025 Jun 20;27(1):41. doi: 10.1007/s11894-025-00991-7.
3
Cohort profile: the Swedish Inception Cohort in inflammatory bowel disease (SIC-IBD).
队列简介:瑞典炎症性肠病初始队列(SIC-IBD)。
BMJ Open. 2025 May 6;15(5):e099218. doi: 10.1136/bmjopen-2025-099218.
4
Leucine-Rich Alpha-2 Glycoprotein 1 as a Biomarker for Evaluation of Inflammatory Bowel Disease Activity in Children.富含亮氨酸的α-2糖蛋白1作为评估儿童炎症性肠病活动度的生物标志物
J Clin Med. 2025 Apr 18;14(8):2803. doi: 10.3390/jcm14082803.
5
Changes of leucine-rich alpha 2 glycoprotein could be a marker of changes of endoscopic and histologic activity of ulcerative colitis.富含亮氨酸的α2糖蛋白的变化可能是溃疡性结肠炎内镜及组织学活动变化的一个标志物。
Sci Rep. 2025 Feb 12;15(1):5248. doi: 10.1038/s41598-025-89615-8.
6
Crohn's disease management: translating STRIDE-II for UK clinical practice.克罗恩病的管理:将STRIDE-II转化应用于英国临床实践
Therap Adv Gastroenterol. 2024 Nov 7;17:17562848241280885. doi: 10.1177/17562848241280885. eCollection 2024.
7
Evaluation of inter- and intra-variability in gut health markers in healthy adults using an optimised faecal sampling and processing method.采用优化的粪便采样和处理方法评估健康成年人肠道健康标志物的个体内和个体间变异性。
Sci Rep. 2024 Oct 19;14(1):24580. doi: 10.1038/s41598-024-75477-z.
8
Faecal calprotectin in primary care: is its current use supported by the evidence?基层医疗中的粪便钙卫蛋白:目前的应用有证据支持吗?
Br J Gen Pract. 2024 Feb 29;74(740):134-136. doi: 10.3399/bjgp24X736665. Print 2024 Mar.
9
Fecal Leukocyte Esterase, an Alternative Biomarker to Fecal Calprotectin in Inflammatory Bowel Disease: A Pilot Series.粪便白细胞酯酶:炎症性肠病中粪便钙卫蛋白的替代生物标志物——一项初步系列研究
Gastro Hep Adv. 2022 Feb 3;1(1):45-51. doi: 10.1016/j.gastha.2021.10.006. eCollection 2022.
10
Fecal calprotectin in pediatric gastrointestinal diseases: Pros and cons.粪便钙卫蛋白在儿童胃肠道疾病中的利弊
World J Clin Pediatr. 2024 Jun 9;13(2):93341. doi: 10.5409/wjcp.v13.i2.93341.